Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
PubMed search Co-administered angiogenesis and cell-migration research investigating the combined contribution of NO/VEGF (BPC-157) and actin-binding (TB-500) pathways
Keeping past expiry discard vials after expiration or noticeable change
research uses 1040 mcg/kg based on animal studies Potential side effects
Targeted Fat Metabolism Unlike systemic weight loss agents, AOD-9604 works by stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat storage) specifically in the areas where its applied, allowing for precise body contouring
48 if separate vials
US$ 27.38
US$ 20.67
US$ 21.12
US$ 23.08
US$ 26.53
US$ 26.00
US$ 22.58
US$ 20.84
US$ 23.13
US$ 22.84
US$ 23.30
